Effect and cellular site of action of cysteine protease inhibitors on the cholesterol esterification pathway in macrophages and Chinese hamster ovary cells.

Stimulation of intracellular cholesterol esterification, which is catalyzed by the enzyme acyl-CoA:cholesterol O-acyltransferase (ACAT), by atherogenic lipoproteins in macrophages is a key step in the development of atheroma foam cells. Since other aspects of intracellular cholesterol metabolism involve proteolytic reactions, we looked for evidence of intracellular proteolysis in the stimulation of the cholesterol esterification pathway. When macrophages and CHO cells were incubated with the cysteine protease inhibitor N-acetylleucylleucylnorleucinal (ALLN), the ability of beta-very-low-density lipoprotein (beta-VLDL) and free cholesterol-rich liposomes to stimulate cholesterol esterification was inhibited by 60-90%. Epoxysuccinylleucylamido-3-methylbutane ethyl ester (EST), a cysteine protease inhibitor structurally different from ALLN, also inhibited beta-VLDL-induced cholesterol esterification in CHO cells. The inhibitory effect of the protease inhibitors could not be explained by decreased net expansion of cellular cholesterol pools, inhibition of lipoprotein cholesteryl ester hydrolysis, or blockage of cholesterol trafficking through the lysosomal pathway. Furthermore, stimulation of cholesterol esterification by 25-hydroxycholesterol and sphingomyelinase was not inhibited by ALLN, indicating that ALLN is not acting as a direct ACAT inhibitor in the cells, and suggesting that the ALLN effect is specific for methods of stimulating cholesterol esterification that expand cellular cholesterol pools. Previous studies have shown that inhibition of protein synthesis (e.g., by cycloheximide) stimulates cholesterol esterification in macrophages and CHO cells, suggesting the presence of a short-lived protein inhibitor of cholesterol esterification. Herein, we show that, when added after cycloheximide, ALLN does not inhibit cycloheximide-induced cholesterol esterification in either cell type. The data in this report are consistent with a novel model in which a proteolytic reaction mediates the stimulation of cholesterol esterification specifically by expanded cellular cholesterol pools. The apparent protease-dependent step is not dependent upon lysosomal trafficking of cholesterol and is proximal to the ACAT enzyme itself; it may function by cleaving an endogenous inhibitor of the interaction of expanded cellular cholesterol pools with ACAT.

[1]  Catherine C. Y. Chang,et al.  Activation of Acyl-Coenzyme A:Cholesterol Acyltransferase by Cholesterol or by Oxysterol in a Cell-free System (*) , 1995, The Journal of Biological Chemistry.

[2]  T. Steck,et al.  Cholesterol homeostasis. Modulation by amphiphiles. , 1994, The Journal of biological chemistry.

[3]  L. Liscum,et al.  A second complementation class of cholesterol transport mutants with a variant Niemann-Pick type C phenotype. , 1994, Journal of lipid research.

[4]  F. Maxfield,et al.  The actin cytoskeleton is important for the stimulation of cholesterol esterification by atherogenic lipoproteins in macrophages. , 1994, The Journal of biological chemistry.

[5]  C Lenfant,et al.  NHLBI funding policies. Enhancing stability, predictability, and cost control. , 1994, Circulation.

[6]  P. Baeuerle,et al.  Sphingomyelinase activates proteolytic I kappa B-alpha degradation in a cell-free system. , 1994, The Journal of biological chemistry.

[7]  X. Hua,et al.  SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis , 1994, Cell.

[8]  J. Slotte,et al.  Cholesterol transport from plasma membranes to intracellular membranes is inhibited by 3 beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. , 1994, Biochimica et biophysica acta.

[9]  F. Maxfield,et al.  Beta-very low density lipoprotein is sequestered in surface-connected tubules in mouse peritoneal macrophages , 1993, The Journal of cell biology.

[10]  K. Cadigan,et al.  Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. , 1993, The Journal of biological chemistry.

[11]  Steven K. Clinton,et al.  The role of macrophages in atherogenesis , 1993 .

[12]  M. Brown,et al.  Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. , 1993, The Journal of biological chemistry.

[13]  Y. Lange,et al.  Role of the plasma membrane in cholesterol esterification in rat hepatoma cells. , 1993, The Journal of biological chemistry.

[14]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[15]  F. Maxfield,et al.  The influence of particle size and multiple apoprotein E-receptor interactions on the endocytic targeting of beta-VLDL in mouse peritoneal macrophages , 1991, The Journal of cell biology.

[16]  I. Tabas,et al.  Lipoproteins activate acyl-coenzyme A:cholesterol acyltransferase in macrophages only after cellular cholesterol pools are expanded to a critical threshold level. , 1991, Journal of Biological Chemistry.

[17]  R. D. Simoni,et al.  Inhibition of degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo by cysteine protease inhibitors. , 1991, The Journal of biological chemistry.

[18]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[19]  S. Mehdi,et al.  Cell-penetrating inhibitors of calpain. , 1991, Trends in biochemical sciences.

[20]  R. Brady,et al.  Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport. , 1991, Developmental neuroscience.

[21]  L. Nagy,et al.  Cholesterol movement between the plasma membrane and the cholesteryl ester droplets of cultured Leydig tumour cells. , 1990, The Biochemical journal.

[22]  F. Maxfield,et al.  Endocytosed beta-VLDL and LDL are delivered to different intracellular vesicles in mouse peritoneal macrophages , 1990, The Journal of cell biology.

[23]  R. Rousson,et al.  Abnormal cholesterol metabolism in imipramine-treated fibroblast cultures. Similarities with Niemann-Pick type C disease. , 1990, Biochimica et biophysica acta.

[24]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[25]  A. Attie,et al.  Rapid intracellular transport of LDL-derived cholesterol to the plasma membrane in cultured fibroblasts. , 1990, Journal of lipid research.

[26]  L. Liscum,et al.  The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. , 1989, The Journal of biological chemistry.

[27]  L. Liscum,et al.  The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts , 1989, The Journal of cell biology.

[28]  Shin-ichiro Takahashi,et al.  Degradation of endogenous proteins and internalized asialofetuin in primary cultured hepatocytes of rats. , 1989, The International journal of biochemistry.

[29]  R. Brady,et al.  Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Slotte,et al.  Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. , 1988, The Biochemical journal.

[31]  W. Rosoff,et al.  Acyl coenzyme A:cholesterol acyl transferase in macrophages utilizes a cellular pool of cholesterol oxidase-accessible cholesterol as substrate. , 1988, The Journal of biological chemistry.

[32]  I. Tabas,et al.  Protein synthesis inhibition in mouse peritoneal macrophages results in increased acyl coenzyme A:cholesterol acyl transferase activity and cholesteryl ester accumulation in the presence of native low density lipoprotein. , 1987, The Journal of biological chemistry.

[33]  A. Tall,et al.  Foam cell-forming J774 macrophages have markedly elevated acyl coenzyme A:cholesterol acyl transferase activity compared with mouse peritoneal macrophages in the presence of low density lipoprotein (LDL) despite similar LDL receptor activity. , 1987, The Journal of clinical investigation.

[34]  C. Chang,et al.  Cycloheximide sensitivity in regulation of acyl coenzyme A:cholesterol acyltransferase activity in Chinese hamster ovary cells. 2. Effect of sterol endogenously synthesized. , 1986, Biochemistry.

[35]  C. Chang,et al.  Cycloheximide sensitivity in regulation of acyl coenzyme A:cholesterol acyltransferase activity in Chinese hamster ovary cells. 1. Effect of exogenous sterols. , 1986, Biochemistry.

[36]  R. Brady,et al.  A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Russell,et al.  Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. , 1985, Annual review of cell biology.

[38]  R. Ross,et al.  Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak Formation , 1984, Arteriosclerosis.

[39]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[40]  Gerrity Rg.  The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981 .

[41]  S. Glagov,et al.  Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. , 1980, The American journal of pathology.

[42]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Krieger,et al.  Replacement of endogenous cholesteryl esters of low density lipoprotein with exogenous cholesteryl linoleate. Reconstitution of a biologically active lipoprotein particle. , 1978, The Journal of biological chemistry.

[44]  M. Brown,et al.  Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[46]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.